ENTITY
3SBio

3SBio (1530 HK)

196
Analysis
Health Care • China
3SBio is a leading biotechnology company engaged in the research, development, manufacturing, and marketing of biopharmaceutical products. The company's diverse portfolio addresses therapeutic areas such as nephrology, oncology, supportive cancer care, inflammation, infectious diseases, autoimmune diseases, metabolism, and dermatology, with key products including EPIAO and TPIAO. 3SBio was founded in 1993 and is headquartered in Shenyang, China.
more
•18 May 2026 14:08

Quiddity Leaderboard Hang Seng Index Jun26: BeOne, Zijin, Cosco Shipping Among Our Top 10 Picks

The Hang Seng Index June 2026 index review results will be publicly announced after market close on 22nd May 2026. In this insight, we have...

Share
bearish•Quantitative Analysis
•17 May 2026 10:10

HK Short Interest Weekly: Tencent, Bidu, CATL, Midea, Meituan, Anta

We analyzed the latest HK SFC report for aggregate short position as of May 8th and highlight short interest changes in Tencent, Bidu, CATL, Midea,...

Logo
102 Views
Share
•26 Jun 2018 15:55

Trade Risks Start to Impact, as China Biotech Ambitions Grow…

Cyclical indicators are softening this month - new orders index for the Philly Fed fell nearly 23 points while Japan’s PMI new export orders...

Logo
311 Views
Share
bullish•Quantitative Analysis
•05 May 2026 16:58

Hong Kong Connect Flows (April): $5.6bn Inflows

We estimate inflows to be $5.6bn from mainland investors to HK stocks in April. We highlight flows for China Mobile, CCB, Pop Mart Intl, ICBC, Yofc.

Logo
190 Views
Share
bullish•Quantitative Analysis
•04 May 2026 11:15

MS-China Index Earning Revision (Apr): KUNLUN TECH, ICBC, CCB, TENCENT, JD.COM, BOC, MEITUAN

We analyzed MS-China's consensus for Apr 2026 and highlighted changes of EPS in KUNLUN TECH, ICBC, CCB, TENCENT, JD.COM, BOC, MEITUAN, CHONGQING...

Logo
526 Views
Share
x